No question, the options offer a very significant leverage for shareholders, against a backdrop of a rising share price, if you believe the company is on the right track with Cvac.
From the companies perspective, the upside is that, if fully converted, the options would generate $63 million in additional cash. (Aside from the actual revenue from the sale of the oppies, maximum of $6.3 million).
Effectively that potentially could substantially offset the need for additional capital raisings in the future.
The money from oppie conversions is likely to start filtering in as soon as the SP reaches 22c. Perhaps after the release of trial results from CAN 003 in the 4th Quarter of 2013?
No question, the options offer a very significant leverage for...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |